Kevin W. Garey - Concepedia

Author

Kevin W. Garey

Also Known As

Garey, K.W., K GAREY, K W Garey, K. Garey, K. W. GAREY, K. W. Garey, K.W. Garey, KEVIN W. GAREY, Kevin Garey, Kevin W Garey

443

Publications

16.1K

Citations

H-Index

127

Concepts

All Affiliations

University of Houston Baylor College of Medicine St. Luke's Episcopal Hospital The University of Texas Health Science Center at Houston Beth Israel Deaconess Medical Center

About

Kevin W. Garey is an author at University of Houston specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	54	6.8K
2	Health Sciences	14	15	959
3	Nursing	2	2	57
4	Education	1	1	17
5	Engineering	1	1	22

Kevin W. Garey

158

Publications

12.6K

Citations

H-Index

Page 1

	Year	Citations
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) L. Clifford McDonald, Dale N. Gerding, Stuart Johnson, Clinical Infectious Diseases Overall Cdi RatesClinical Practice GuidelinesClostridium Difficile InfectionTraveler DiarrheaHealthcare Epidemiology	2017	2.6K
Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study Kevin W. Garey, M Rege, Manjunath P. Pai, Clinical Infectious Diseases	2006	1.1K
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) L. Clifford McDonald, Dale N. Gerding, Stuart Johnson, Clinical Infectious Diseases Overall Cdi RatesClinical Practice GuidelinesClostridium Difficile InfectionTraveler DiarrheaHealthcare Epidemiology	2018	1.1K
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of <i>Clostridioides difficile</i> Infection in Adults Stuart Johnson, Valéry Lavergne, Andrew M Skinner, Clinical Infectious Diseases Focused UpdateHealthcare EpidemiologyAntimicrobial StewardshipHealthcare-associated InfectionClinical Epidemiology	2021	574
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial Eleftherios Mylonakis, Cornelius J. Clancy, Luis Ostrosky‐Zeichner, Clinical Infectious Diseases	2015	425
Bifidobacterium dentium Fortifies the Intestinal Mucus Layer via Autophagy and Calcium Signaling Pathways Melinda A. Engevik, Berkley Luk, Alexandra L. Chang‐Graham, mBio	2019	268
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of <i>Clostridioides difficile</i> Infection in Adults Stuart Johnson, Valéry Lavergne, Andrew M Skinner, Clinical Infectious Diseases Healthcare EpidemiologyAntimicrobial StewardshipHealthcare-associated InfectionClinical EpidemiologyDrug Monitoring	2021	188
A randomized, double-blind, placebo-controlled pilot study to assess the ability of rifaximin to prevent recurrent diarrhoea in patients with Clostridium difficile infection Kevin W. Garey, Shashank S. Ghantoji, Dhara N. Shah, Journal of Antimicrobial Chemotherapy	2011	170
FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia Nicholas D. Beyda, J. John, Mohammad Jahangir Alam, Clinical Infectious Diseases	2014	170
Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel Cornelius J. Clancy, Peter G. Pappas, José A. Vázquez, Clinical Infectious Diseases	2017	164

Page 1